Rankings
▼
Calendar
CAMP Q1 2019 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$126M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$84M
-10.6% YoY
Gross Profit
$33M
39.7% margin
Operating Income
$15M
18.3% margin
Net Income
$11M
13.3% margin
EPS (Diluted)
$0.33
QoQ Revenue Growth
-4.6%
Cash Flow
Operating Cash Flow
-$353,000
Free Cash Flow
-$3M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$604M
Total Liabilities
$398M
Stockholders' Equity
$206M
Cash & Equivalents
$257M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$84M
$94M
-10.6%
Gross Profit
$33M
$38M
-12.9%
Operating Income
$15M
$2M
+693.3%
Net Income
$11M
-$5M
+336.3%
Revenue Segments
Product
$64M
76%
Application Subscriptions And Related Products And Other Services
$20M
24%
Geographic Segments
UNITED STATES
$60M
68%
E M E A
$12M
14%
South America
$10M
11%
Asia Pacific
$3M
4%
CANADA
$3M
3%
← FY 2019
All Quarters
Q2 2019 →